Daniela Araiza-Olivera

Fox Chase Cancer Center, Temple Health, Philadelphia, PA, United States.

27 publications 2010 – 2025 ORCID

What does Daniela Araiza-Olivera research?

Daniela Araiza-Olivera studies how specific genetic mutations, like KRAS G12V, affect the behavior of colorectal cancer cells. By understanding how these cells change their metabolism to grow, she investigates ways to make them more susceptible to existing treatments. Her research highlights the importance of a protein called ACSS2, which plays a crucial role in the growth of cancer cells with this mutation. By targeting this protein, she aims to enhance the effectiveness of therapies for patients suffering from this specific type of colorectal cancer.

Key findings

  • Colorectal cancer cells with the KRAS G12V mutation depend on ACSS2 for their growth, providing a specific target for treatment.
  • Blocking ACSS2 could make KRAS G12V mutant cells more vulnerable to certain therapies, potentially improving treatment outcomes.
  • This research offers insights into how different mutations in colorectal cancer respond to therapies, paving the way for personalized treatment approaches.

Frequently asked questions

Does Dr. Araiza-Olivera study colorectal cancer?
Yes, she specializes in colorectal cancer, focusing on the KRAS G12V mutation.
What treatments has Dr. Araiza-Olivera researched?
She explores how targeting the protein ACSS2 can enhance therapy effectiveness for patients with the KRAS G12V mutation.
Is Dr. Araiza-Olivera's work relevant to patients with KRAS mutations?
Yes, her research specifically benefits patients with the KRAS G12V mutation in colorectal cancer.

Publications in plain English

Prenatal exposure to Bisphenol-A as a risk factor for infant neurodevelopment.

2025

Frontiers in endocrinology

Bello-Cortes IH, García-García JA, Gutiérrez-Aguilar M, Araiza-Olivera D, Sánchez-Pérez C +5 more

Plain English
This study looked at how exposure to Bisphenol A (BPA), a chemical often found in food packaging, during pregnancy affects babies' brain development. The researchers found that 80% of the studies they reviewed showed a link between maternal BPA exposure and behavioral problems in children, with male infants being at higher risk if they were exposed to BPA during the last three months of pregnancy. This is important because it suggests that taking steps to limit BPA exposure could help protect the brain development of babies and reduce future mental health issues. Who this helps: This helps expecting mothers and healthcare providers.

PubMed

Identifying and Targeting Key Driver Genes for Collagen Production within the 11q13/14 Breast Cancer Amplicon.

2025

Molecular cancer research : MCR

Araiza-Olivera D, Prudnikova TY, Uribe-Alvarez C, Cai KQ, Franco-Barraza J +3 more

Plain English
This study looked at specific genes on chromosome 11 that are linked to a type of breast cancer with a poor survival rate of just 5 years. Researchers discovered two genes, SERPINH1 and P4HA3, that play a key role in producing collagen, a protein that makes tissues stiff and can lead to more aggressive cancer. When they blocked these genes in lab tests and animal models, they found it slowed down cancer growth and could be a new way to treat this type of breast cancer. Who this helps: Patients with the 11q13/14 breast cancer type.

PubMed

KRAS G12V mutation-selective requirement for ACSS2 in colorectal adenoma formation.

2025

Cell reports

Budagyan K, Cannon AC, Chatoff A, Benton D, Kurimchak AM +6 more

Plain English
This study focused on how a specific type of KRAS mutation, called KRAS G12V, affects cell metabolism in colorectal cancer. Researchers discovered that cells with this mutation rely heavily on a protein called ACSS2 for growth, making them more vulnerable to certain treatments when ACSS2 is blocked. They found that targeting ACSS2 could help improve treatment effectiveness for patients with this mutation, which is important because different mutations can respond differently to therapies. Who this helps: This research benefits patients with KRAS G12V colorectal cancer.

PubMed

Identifying and targeting key driver genes for collagen production within the 11q13/14 breast cancer amplicon.

2024

bioRxiv : the preprint server for biology

Araiza-Olivera D, Prudnikova TY, Uribe-Alvarez C, Cai KQ, Franco-Barraza J +3 more

Plain English
This research focused on a specific group of breast cancer called IntClust-2, which is linked to poor survival rates of about five years. The scientists studied 198 genes on a part of chromosome 11 that was found to be amplified in this cancer type. They discovered two new genes that help produce collagen, which is important for tumor growth, and blocking these genes reduced cancer cell growth in lab tests and in animals. Who this helps: This research benefits patients with IntClust-2 breast cancer by opening up new treatment options.

PubMed

Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints.

2024

Oncogene

Cannon AC, Budagyan K, Uribe-Alvarez C, Kurimchak AM, Araiza-Olivera D +5 more

Plain English
This study looked at a specific type of skin cancer called melanoma that has mutations in a gene called RAC1, which makes it harder to treat. Researchers found that blocking a protein called CDK9 not only slowed down the growth of these RAC1-mutant melanoma cells but also made them more responsive to an immune therapy. In experiments, this combination treatment significantly reduced tumor growth, showing that targeting CDK9 could improve outcomes for patients with this type of melanoma. Who this helps: Patients with RAC1-mutant melanoma.

PubMed

The cytotoxicity effect of 7-hydroxy-3,4-dihydrocadalene fromand semisynthetic cadalenes derivates towards breast cancer cells: involvement of oxidative stress-mediated apoptosis.

2023

PeerJ

Mendoza-Fuentes A, González-Burgos E, Aparicio Trejo OE, Delgado-Lamas G, Rodríguez-Chávez JL +3 more

Plain English
This study looked at a natural compound called 7-hydroxy-3,4-dihydrocadalene and its ability to kill breast cancer cells. The researchers found that this compound significantly reduced the survival of breast cancer cells (specifically, the MCF7 cell line) in a dose- and time-dependent way, which means the more of the compound they used, the less viable the cancer cells became. It also triggered stress in the cells, leading to their death, while its semi-synthetic versions did not work as effectively. Who this helps: This benefits patients with breast cancer by providing potential new treatment options.

PubMed

Unique vulnerability of-mutant melanoma to combined inhibition of CDK9 and immune checkpoints.

2023

bioRxiv : the preprint server for biology

Cannon AC, Budagyan K, Uribe-Alvarez C, Kurimchak AM, Araiza-Olivera D +5 more

Plain English
This study focused on a specific type of melanoma with a RAC1 mutation, which is linked to worse outcomes and resistance to treatment. Researchers discovered that blocking a protein called CDK9 slowed the growth of these cancer cells and made them more responsive to an immune therapy called anti-PD-1. Specifically, combining CDK9 inhibition with anti-PD-1 treatment significantly reduced tumor growth in RAC1-mutant melanoma. Who this helps: This benefits patients with RAC1-mutant melanoma who may have limited treatment options.

PubMed

Diastereomeric Separation of Chiral-Tricarbonyl(iminopyridine) Rhenium(I) Complexes and Their Cytotoxicity Studies: Approach toward an Action Mechanism against Glioblastoma.

2022

Journal of medicinal chemistry

Suárez-Ortiz GA, Hernández-Correa R, Morales-Moreno MD, Toscano RA, Ramirez-Apan MT +3 more

Plain English
Researchers created new rhenium compounds using specific chiral molecules and tested how effective these compounds were at killing cancer cells, particularly glioblastoma, which is a type of brain cancer. They found that the different shapes (or diastereoisomers) of these compounds had a significant impact on their ability to kill cancer cells, influencing factors like cell growth and movement. This discovery is important because it highlights how the structure of these compounds can be targeted to improve cancer treatment. Who this helps: This helps patients with glioblastoma and doctors treating this challenging cancer.

PubMed

The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells.

2022

Science signaling

Kurimchak AM, Herrera-Montávez C, Montserrat-Sangrà S, Araiza-Olivera D, Hu J +6 more

Plain English
Researchers studied how cancer cells develop resistance to a new type of drug called PROTACs, which are designed to eliminate specific proteins that help cancer grow. They discovered that a protein called MDR1 increases in abundance in resistant cancer cells, making the PROTACs less effective. By either removing or blocking MDR1, they were able to improve the effectiveness of PROTACs, showing that combining these drugs with MDR1 inhibitors led to better treatment outcomes in mouse models of colorectal cancer. Who this helps: This benefits patients with colorectal cancer who struggle with treatment resistance.

PubMed

PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2).

2021

Human molecular genetics

Hawley E, Gehlhausen J, Karchugina S, Chow HY, Araiza-Olivera D +14 more

Plain English
This study looked at the role of a protein called PAK1 in mice with Neurofibromatosis Type 2 (NF2), a condition that leads to tumor growth. Researchers found that blocking PAK1 reduced tumor sizes and improved the lifespan of these mice, although the effect was small. Specifically, while a general PAK inhibitor had little impact, removing the Pak1 gene reduced tumors significantly, showing that targeting PAK1 could be an effective treatment strategy for patients with NF2. Who this helps: This helps patients with Neurofibromatosis Type 2 by potentially leading to more effective treatments.

PubMed

Targeting effector pathways in RAC1-driven malignant melanoma.

2021

Small GTPases

Uribe-Alvarez C, Guerrero-Rodríguez SL, Rhodes J, Cannon A, Chernoff J +1 more

Plain English
Researchers studied malignant melanoma, a type of skin cancer that often has mutations in the RAC1 gene, affecting 4-9% of sun-exposed cases. They found that specific drugs targeting certain pathways linked to RAC1 can effectively slow the growth of melanoma cells driven by this mutation but have little effect on cells driven by a different mutation called BRAF. This is important because it suggests new treatment options for patients with RAC1-driven melanoma, potentially leading to better outcomes. Who this helps: This helps patients with RAC1-driven malignant melanoma.

PubMed

In Saccharomyces cerevisiae, withdrawal of the carbon source results in detachment of glycolytic enzymes from the cytoskeleton and in actin reorganization.

2020

Fungal biology

Espinoza-Simón E, Chiquete-Félix N, Morales-García L, Pedroza-Dávila U, Pérez-Martínez X +3 more

Plain English
This study looked at how the removal of sugar affects certain enzymes in yeast cells. Researchers found that when sugar was taken away, the enzymes needed for processing sugar stopped working efficiently and separated from the cell's support structure, leading to a drop in energy production (ATP). Adding sugar back restored both energy levels and the function of these enzymes, which is important for understanding how yeast cells manage energy and metabolism. Who this helps: This helps yeast researchers and those in industries relying on fermentation, like brewing and baking.

PubMed

Fluorescent Probe for Transmembrane Dynamics during Osmotic Effects.

2020

Analytical chemistry

Palacios-Serrato E, Araiza-Olivera D, Jiménez-Sánchez A

Plain English
This study focused on how changes in osmotic pressure affect the structures around mitochondria (the energy factories in cells) and their function during cell death. Researchers developed a new fluorescent probe that tracked these changes, finding that mitochondrial polarity increased significantly when osmotic pressure was applied, indicating stress on the cell. This advancement allows scientists to better understand cell health and death, which is crucial for developing treatments for diseases. Who this helps: This helps researchers and doctors who study cell health and diseases like cancer.

PubMed

From bench to bedside: Biosensing strategies to evaluate endocrine disrupting compounds based on epigenetic events and their potential use in medicine.

2020

Environmental toxicology and pharmacology

Araiza-Olivera D, Gutierrez-Aguilar M, Espinosa-García AM, García-García JA, Tapia-Orozco N +5 more

Plain English
This research focused on how exposure to certain chemicals, known as endocrine disruptors (EDCs), can lead to health problems like cancer, obesity, and diabetes. It found that these chemicals affect our genes in ways that can be measured, specifically through changes in DNA, known as methylation, which can reveal how much someone has been exposed to EDCs. Understanding these changes is important for improving medical tests and treatments related to these health issues. Who this helps: Patients affected by diseases linked to endocrine disruptors and healthcare providers diagnosing and treating them.

PubMed

Synthesis, structure, and biological activity of bis(benzimidazole)amino thio- and selenoether nickel complexes.

2020

Journal of inorganic biochemistry

Muñoz-Patiño N, Sánchez-Eguía BN, Araiza-Olivera D, Flores-Alamo M, Hernández-Ortega S +2 more

Plain English
Researchers created four new nickel compounds and studied their structure and how they behave in the lab. They found that three of these compounds form pairs in solid form but exist as single units in liquid, and tested their ability to kill cancer cells. One compound showed promising results by effectively targeting human cells, which is important for developing better cancer treatments. Who this helps: This research benefits cancer patients and doctors looking for more effective therapies.

PubMed

Exposure to bisphenol A: current levels from food intake are toxic to human cells.

2019

Molecular biology reports

Hernández-Hernández KL, Tapia-Orozco N, Gimeno M, Espinosa-García AM, García-García JA +5 more

Plain English
This study looked at the effects of bisphenol A (BPA), a chemical found in many foods, on human cells. Researchers found that at levels present in food, BPA can be harmful to cells, with specific harmful concentrations starting at 50 micrograms per milliliter (μg/mL). The study showed that different types of cells reacted differently to BPA, with breast cancer cells being affected at lower levels (64.67 μg/mL) compared to prostate cancer and mouse cells (85.17 μg/mL and 88.48 μg/mL, respectively). This is important because it indicates that BPA exposure from food could be damaging to human health. Who this helps: This helps patients concerned about the health risks of chemicals in their food.

PubMed

Organotin(iv) differential fluorescent probe for controlled subcellular localization and nuclear microviscosity monitoring.

2019

Chemical communications (Cambridge, England)

Bernal-Escalante J, López-Vázquez A, Araiza-Olivera D, Jiménez-Sánchez A

Plain English
This study developed a new tool to monitor changes in the thickness of the environment inside cell nuclei, which can indicate damage caused by certain harmful substances. The tool can measure how fluid or thick the nuclear environment becomes, enabling researchers to track nuclear damage effectively. This is important because it can help scientists understand how different agents affect cells, potentially leading to better treatments for related health issues. Who this helps: This helps researchers and medical professionals studying cell damage and treatments for diseases.

PubMed

A simple method for mitochondrial respiration and calcium uptake assessment in pollen tubes.

2019

MethodsX

Ortiz-Jiménez DJ, López-Aquino CM, Flores-Herrera C, Preciado-Linares G, Gonzalez-Vizueth I +3 more

Plain English
This study focused on finding a new and simple way to measure important activities of mitochondria, which are the energy-producing parts of cells, in pollen tubes from tobacco plants. The researchers developed a method to directly assess how well these mitochondria use oxygen and manage calcium, which are crucial for their function. This is significant because it allows scientists to study mitochondrial activities in a way that wasn't possible before, potentially leading to better understanding of plant biology. Who this helps: This helps researchers studying plant biology and anyone interested in improving plant growth and health.

PubMed

Hras helps hippo heterodimerize to evade tumor suppression.

2018

Small GTPases

Araiza-Olivera D, Chernoff J

Plain English
This research studied how a protein called Hras helps another group of proteins, the Mst1 and Mst2 kinases, work together in a way that helps cancer cells avoid death. The study found that when Hras is activated, it encourages these proteins to form pairs (heterodimers) that are less effective in stopping tumor growth compared to when they work alone. This is important because it shows one way that cancer can develop by interfering with the body’s natural tumor suppression mechanisms. Who this helps: This helps patients at risk for or currently facing cancer.

PubMed

Suppression of RAC1-driven malignant melanoma by group A PAK inhibitors.

2018

Oncogene

Araiza-Olivera D, Feng Y, Semenova G, Prudnikova TY, Rhodes J +1 more

Plain English
This study looked at how a specific gene mutation in RAC1 contributes to malignant melanoma, a serious skin cancer, and tested new treatment options. Researchers found that while melanoma cells with the RAC1 mutation resist traditional drugs, they are highly responsive to inhibitors of a protein called PAK, potentially making these inhibitors effective treatments. This research is important because it highlights a new way to target hard-to-treat melanoma, which could lead to better outcomes for patients. Who this helps: This helps patients with RAC1-mutant malignant melanoma.

PubMed

Bichromophoric Sensors for Ratiometric Measurements of Molecular Microenvironments through the Interplay of Charge Transfer and Energy Transfer Channels.

2018

ChemPlusChem

Arroyo-Pieck A, Araiza-Olivera D, Peon J

Plain English
Researchers developed new sensors that can measure changes in molecular environments by using two different dyes. They found that the signal from one dye depends on the surrounding conditions, specifically showing a twofold increase in sensitivity based on the polarity of the environment. This is important because it allows for accurate readings without interference, and the sensors work well in live cells, helping to visualize conditions like normal cell health and cell death. Who this helps: This benefits researchers and doctors studying cellular processes and diseases, like cancer.

PubMed

H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 Heterodimerization.

2016

Current biology : CB

Rawat SJ, Araiza-Olivera D, Arias-Romero LE, Villamar-Cruz O, Prudnikova TY +2 more

Plain English
This study examined how the protein kinases Mst1 and Mst2, which help prevent tumor formation, are influenced by another protein called H-ras. Researchers found that H-ras promotes the pairing of Mst1 and Mst2 in a way that reduces their ability to work effectively, making them less capable of stopping tumors. This is significant because it uncovers how H-ras can drive cancer development by hindering these protective proteins. Who this helps: This helps patients at risk of certain cancers, as understanding this mechanism could lead to better treatment strategies.

PubMed

Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibition.

2016

Oncotarget

Villamar Cruz O, Prudnikova TY, Araiza-Olivera D, Perez-Plasencia C, Johnson N +5 more

Plain English
Researchers studied how shutting down a protein called PAK1 affects breast cancer cells that do not have mutations in the FA/BRCA genes. They found that reducing PAK1 made these cells more sensitive to PARP inhibitors, leading to increased cell death and slower tumor growth. Specifically, combining PAK1 inhibition with PARP inhibitors boosted cell death and reduced the ability of the cancer cells to grow and form colonies. Who this helps: This research benefits patients with breast cancer who do not have FA/BRCA mutations, by potentially offering them new treatment options.

PubMed

A glycolytic metabolon in Saccharomyces cerevisiae is stabilized by F-actin.

2013

The FEBS journal

Araiza-Olivera D, Chiquete-Felix N, Rosas-Lemus M, Sampedro JG, Peña A +2 more

Plain English
This research focused on how a group of enzymes in yeast (Saccharomyces cerevisiae) works together to turn sugar into alcohol and carbon dioxide efficiently. The study found that a structure called F-actin helps keep these enzymes grouped together, which boosts their activity by making the process faster and protecting them from being blocked; specifically, it showed enhanced fermentation activity and resilience against certain inhibitors. This is important because improving enzyme efficiency can lead to better alcohol production processes in industries like brewing and biofuels. Who this helps: This benefits yeast biotechnologists and industries that rely on fermentation, such as brewing and biofuel production.

PubMed

A critical tyrosine residue determines the uncoupling protein-like activity of the yeast mitochondrial oxaloacetate carrier.

2012

The Biochemical journal

Luévano-Martínez LA, Barba-Ostria C, Araiza-Olivera D, Chiquete-Félix N, Guerrero-Castillo S +3 more

Plain English
Researchers studied a protein in yeast that helps transport certain molecules across cell membranes. They found that a specific amino acid, tyrosine, is crucial for this protein to act like an uncoupling protein, which helps regulate energy usage in cells. When they altered this amino acid, the protein lost its ability to transport protons, highlighting its importance in energy processes. Who this helps: This helps scientists and researchers focused on metabolic diseases and energy regulation in cells.

PubMed

Physiological uncoupling of mitochondrial oxidative phosphorylation. Studies in different yeast species.

2011

Journal of bioenergetics and biomembranes

Guerrero-Castillo S, Araiza-Olivera D, Cabrera-Orefice A, Espinasa-Jaramillo J, Gutiérrez-Aguilar M +3 more

Plain English
This study looked at how different types of yeast prevent damage to their cells caused by oxygen consumption when their energy production systems are pushed to work harder. Researchers found that some yeasts, like *Saccharomyces cerevisiae* and *Debaryomyces hansenii*, have special systems in place that control oxygen use, preventing harmful reactions that produce dangerous molecules called reactive oxygen species (ROS). Understanding these mechanisms is important because they help manage the balance of energy production and protect cells from damage, which could have implications for broader biological systems and health. Who this helps: This research benefits scientists studying cellular energy production and potential treatments for conditions related to oxidative stress.

PubMed

The association of glycolytic enzymes from yeast confers resistance against inhibition by trehalose.

2010

FEMS yeast research

Araiza-Olivera D, Sampedro JG, Mújica A, Peña A, Uribe-Carvajal S

Plain English
This study looked at how certain enzymes in yeast respond to trehalose, a substance that can inhibit their activity during stress. The researchers found that while trehalose blocked the activity of two specific enzymes, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and hexokinase (HXK), they were protected from this inhibition when paired with other enzymes like aldolase (ALD) or phosphoglycerate kinase (PGK). This matters because it shows that enzyme interactions can help yeast maintain their metabolism and continue producing energy even when faced with stressful conditions. Who this helps: This helps yeast researchers and those in industries relying on fermentation, such as brewing and biofuel production.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.